Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability.
about
Anti-Tumour Necrosis Factor Therapy for Paediatric Crohn's Disease: Improved Benefits Through Treatment Optimisation, Deeper Understanding of Its Risks, and Reduced Costs due to Biosimilar Availability.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Anti-Tumour Necrosis Factor Th ...... ue to Biosimilar Availability.
@en
Anti-Tumour Necrosis Factor Th ...... ue to Biosimilar Availability.
@nl
type
label
Anti-Tumour Necrosis Factor Th ...... ue to Biosimilar Availability.
@en
Anti-Tumour Necrosis Factor Th ...... ue to Biosimilar Availability.
@nl
prefLabel
Anti-Tumour Necrosis Factor Th ...... ue to Biosimilar Availability.
@en
Anti-Tumour Necrosis Factor Th ...... ue to Biosimilar Availability.
@nl
P2860
P1433
P1476
Anti-Tumour Necrosis Factor Th ...... due to Biosimilar Availability
@en
P2093
J N Samsom
M A Cozijnsen
P2860
P2888
P356
10.1007/S40272-017-0266-9
P50
P577
2018-02-01T00:00:00Z